EPLAW PATENT BLOG

NL – Ruby Decor v. Basic Holdings / Appeal

Posted: August 30th, 2017

Ruby Decor B.V. and Aparto B.V. v. Basic Holdings ULC, Court of Appeal The Hague, 22 August 2017, Case No. ECLI:NL:GHDHA:2017:2409, with thanks to Alexander Tsoutsanis, DLA Piper, for sending in the judgment as well as an English translation thereof  Artificial fireplaces. Earlier, the Judge in PI proceedings ruled that in his preliminary opinion Ruby Decor did […]

READ MORE

NL – Mobile Sanitary Solutions v. TWT Verhuur

Posted: July 31st, 2017

Mobile Sanitary Solutions B.V. v. TWT Verhuur B.V., Summary Judge of the District Court of The Hague, 28 July 2017, Case No. ECLI:NL:RBDHA:2017:8486 Patent Holder Mobile Sanitary Solutions alleges infringement. TWT states that the patent invoked is invalid. In a preliminary ruling the summary judge agrees with TWT and holds that the patent is likely […]

READ MORE

NL – Carl Zeiss v. VSY

Posted: June 9th, 2017

Carl Zeiss Meditec AG v. VSY Biotechnology B.V. et al., District Court The Hague, The Netherlands, 7 June 2017, Case No. ECLI:NL:RBDHA:2017:6136 European Patent on an intraocular (implantable) lens. Interpretation of claims. The Dutch part of the patent is valid: the hurdles of novelty, inventive step and enablement were all taken successfully. The patent is […]

READ MORE

NL – Sun v. Novartis / Supreme Court

Posted: May 8th, 2017

Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Supreme Court of the Netherlands, 14 April 2017, Case No. ECLI:NL:HR:2017:692 Preliminary injunction proceedings. Patent for second medical indication. Swiss-type claim. Novartis owns EP 1 296 689 with a Swiss type claim for use of zoledronic acid in the preparation of a medicament for the treatment of […]

READ MORE

HU – PI prevents Pharmaceutical Product launch

Posted: March 14th, 2017

Budapest Court Grants Preliminary Injunction Based on Direct Threat of Patent Infringement Preventing Pharmaceutical Product Launch The Metropolitan Court, Budapest has recently issued an order granting preliminary injunction against a Hungarian pharmaceutical distributor. The specialty of the case is that the allegedly infringing pharmaceutical product was not yet launched and it is the first time […]

READ MORE

NL – Eli Lilly v. Sandoz

Posted: March 6th, 2017

Eli Lilly Company v. Sandoz B.V., District Court the Hague, 1 March 2017, Case No. ECLI:NL:RBDHA:2017:1907 Preliminary injunction proceedings. It is unlikely that the patent will be revoked in proceedings on the merits. No implicit disclosure of the administering of vitamine B12. Injunction granted. A copy of the judgment can be read here.

READ MORE

FR – Warner-Lambert & Pfizer v. generics / Pregabalin PI

Posted: January 20th, 2017

Pregabalin PI in France: a decision dealing with skinny label, second medical use claims and contributory infringement A new pregabalin decision has been rendered on December 2, 2016 in France, in a PI litigation initiated by Warner-Lambert (hereafter: the patentee) and licensees Pfizer against 9 groups of generic companies (hereafter: the defendants). All defendants are […]

READ MORE

NL – DSM v. Novozymes

Posted: January 11th, 2017

DSM IP Assets B.V. v. Novozymes A/S, PI Judge of the District Court of The Hague, The Netherlands, 6 January 2017, Case No. ECLI:NL:RBDHA:2017:110 DSM holps a patent entitled ‘Enzyme preparation yielding a clean taste’. During Opposition, the patent was limited to milk sterilised at ultra high temperatures (‘UHT milk’). An appeal at the TBA […]

READ MORE

ES – Abbott v. Kern / Fenofibrate 145 (Interim injunction appeal)

Posted: November 15th, 2016

Abbott Products Operations AG v. Kern Pharma S.L., Court of Appeals (15th Division) of Barcelona, Spain, 15 September 2016, Docket No. 163/2016. In a Decision rendered on 15 September 2016, the Court of Appeals of Barcelona granted the interim injunctions requested by Abbott against Kern Pharma’s generic Fenofibrate 145 mg. The Court reversed the previous […]

READ MORE